Evidence map›Paper›PMID 41087495›Full record

ArticleScientific reports2025

Development and validation of a machine learning-based model to predict the risk of hospitalization death in hospitalized patients with AECOPD.

Yan Zhang, Shuping Zheng, Dan Wang, Fanjie Lin, Yu Ma, Zhihui Qiang, Tianyi Zhang, Haicheng Zhong, Miaomiao Zhou, Zhuoyang Li and 4 more

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yan ZhangDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Shuping ZhengDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Dan WangDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Fanjie LinState Key Laboratory of Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yu MaDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhihui QiangDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Tianyi ZhangDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Haicheng ZhongDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Miaomiao ZhouDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhuoyang LiDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Penggang ChenDepartment of Information, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an , Shaanxi, China.
Jieyu FengGuangzhou Tianpeng Technology Co., Ltd., Guangzhou, Guangdong, China.
Wenju LuState Key Laboratory of Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. wlu92@gzhmu.edu.cn.
Yun LiuDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. yunliusx@163.com.

Funding

National Natural Science Foundation of China 82070035
6 · The paper itself

Abstract

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a leading cause of hospitalization and death in COPD patients. Machine learning (ML) approach is powerful but has a "black box" issue with an undirect interpretation of the ML technique. Herein, we conducted a multicentre, retrospective cohort study in two tertiary hospitals across China, primarily utilizing echocardiographic variables to build and validate an explainable prediction model based on a ML approach to predict the hospitalization death of AECOPD. For model explainability, we utilized a model-agnostic SHapley Additive exPlanations explainer to interpret the output of our final model. Our results showed that the light gradient boosting machine (LightGBM) model achieved the best performance among the 11 ML models. After reducing features according to the feature importance rank, an explainable final LightGBM model was established with 9 features (AUC = 0.956, accuracy = 92.1%, sensitivity = 0.891, specificity = 0.933, PPV = 0.852, NPV = 0.952, F1 score = 0.871). To facilitate its utility for clinicians, this final explainable model had been translated into a convenient application. In addition, the LightGBM model mitigated the concern of the "black-box" via a global and a local explanation of the SHAP method. A publicly accessible web tool was generated for the model. These findings further hold promise for guiding clinical management and improving patient outcomes.

Indexed as

HospitalizationMachine LearningPulmonary Disease, Chronic ObstructiveAgedChinaFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAcute exacerbationCOPDMachine learningPrediction modelSHAP

Identifiers

PMID41087495
PMCPMC12521379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.